The TP53 pathway-related gene MDM2 was commonly amplified in BC (8.7%; copy number variant [CNV] 8.72%, short variant [SV] 0.14%) and NSCLC (4.40%; CNV 4.38%, SV 0.0014%). This evidence concerns the gene MDM2 and non-small cell lung carcinoma.